Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06640257 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis

StatusActive, Not Recruiting
PhasePhase 3
Started2024-11-04
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 36 days later Apr 30, 2026 → Jun 5, 2026
See other at-risk trials from Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Amendment history

2026-08-04
Study Status, Study Design, Contacts/Locations v2
Enrollment closed, study ongoing
Primary completion pushed: 2026-04-30 → 2026-06-05
Completion pushed: 2026-06-30 → 2027-01-30
Enrollment targetestimated 200→confirmed 208
Study sitesdetails revised at 1 of 1 site
2024-11-08
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-10-14→confirmed 2024-11-04
Study sitesdetails revised at 1 of 1 site
2024-10-10
Original filing
This study is a randomized, double-blind, multicenter, placebo-controlled Phase III clinical study, consisting of a 4-week screening period, a 24-week core treatment period, a 24-week maintenance treatment period, and an 8-week safety follow-up period. It is planned to include 150 adult subjects with psoriatic arthritis.
Trial Details
NCT Number NCT06640257
Lead Sponsor Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Conditions Psoriatic Arthritis
Enrollment 208 participants
Start Date 2024-11-04
Primary Completion 2026-06-05 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-06